Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus–Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco-25-00835
Authors: Haitham Mirghani, Anne Aupérin, Caroline Even, Alicia Larive, Jerome Fayette, Lionnel Geoffrois, Florian Clatot, Benoit Calderon, Yungan Tao, France Nguyen, Emmanuelle Fabiano, Sarah Kreps, Anne-Laure Gaultier, Francois Bidault, Julien Puech, Benjamin Morin, Lea Picavet, Eric Tartour, Aicha Ben Hariz, Michael Chevrot, Laure Monard, David Veyer, Cecile Badoual, Helene Péré, Pierre Blanchard
Institutions: Inserm, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Paris Cardiovascular Research Center, Université Paris-Saclay, Institut Gustave Roussy, La Ligue Contre le Cancer, Fondation Gustave Roussy, Centre Léon Bérard, Institut de Cancérologie de Lorraine, Centre Henri Becquerel, Centre de Recherche des Cordeliers, Génomique Fonctionnelle des Tumeurs Solides, UniCancer Group, Centre de recherche en Epidémiologie et Santé des Populations
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7125485986